Screening for viral markers in volunteer and replacement blood donors in West Africa
Identifieur interne : 001105 ( Main/Exploration ); précédent : 001104; suivant : 001106Screening for viral markers in volunteer and replacement blood donors in West Africa
Auteurs : F. Sarkodie [Ghana] ; M. Adarkwa [Ghana] ; Y. Adu-Sarkodie [Ghana] ; D. Candotti [Royaume-Uni] ; J. W. Acheampong [Ghana] ; J. P. Allain [Royaume-Uni]Source :
- Vox Sanguinis [ 0042-9007 ] ; 2001-04.
Descripteurs français
- KwdFr :
- ARN viral (sang), Adolescent, Adulte, Adulte d'âge moyen, Anticorps anti-HTLVI (sang), Anticorps anti-HTLVII (sang), Anticorps anti-VIH (sang), Anticorps antiviraux (sang), Anticorps de l'hépatite C (sang), Antigènes de surface du virus de l'hépatite B (sang), Antigènes viraux (sang), Bénévoles, Donneurs de sang, Dépistage systématique, Famille, Femelle, Ghana (épidémiologie), Humains, Mâle, Protéine de capside p24 du VIH (sang), Séroprévalence du VIH, Test ELISA, Transfusion sanguine (effets indésirables), Virémie (), Virémie (diagnostic), Virémie (sang), Virémie (transmission), Virémie (épidémiologie), Études séroépidémiologiques.
- MESH :
- diagnostic : Virémie.
- effets indésirables : Transfusion sanguine.
- sang : ARN viral, Anticorps anti-HTLVI, Anticorps anti-HTLVII, Anticorps anti-VIH, Anticorps antiviraux, Anticorps de l'hépatite C, Antigènes de surface du virus de l'hépatite B, Antigènes viraux, Protéine de capside p24 du VIH, Virémie.
- épidémiologie : Ghana, Virémie.
- Wicri :
- geographic : Ghana.
- topic : Adolescent, Adulte, Adulte d'âge moyen, Bénévoles, Donneurs de sang, Dépistage systématique, Famille, Femelle, Humains, Mâle, Séroprévalence du VIH, Test ELISA, Transfusion sanguine, Don, Virémie, Zone urbaine, Études séroépidémiologiques.
English descriptors
- KwdEn :
- Adolescent, Adult, Allain, Antibodies, Viral (blood), Antigens, Viral (blood), Assay, Blackwell science, Blood Donors, Blood Transfusion (adverse effects), Blood donations, Blood donor population, Blood donors, Blood screening, Blood service, Blood services, Blood transfusion, Donation, Donor, East anglia blood centre, Enzyme immunoassay, Enzyme-Linked Immunosorbent Assay, Equatorial guinea, Family, Female, Ghana (epidemiology), Grey bars, HIV Antibodies (blood), HIV Core Protein p24 (blood), HIV Seroprevalence, HTLV-I Antibodies (blood), HTLV-II Antibodies (blood), Hbsag, Hbsag prevalence, Hepatitis, Hepatitis B Surface Antigens (blood), Hepatitis C Antibodies (blood), Hepatocellular carcinoma, High level, Human virus, Humans, Infection, International society, Komfo anokye teaching hospital, Kumasi, Male, Marker, Mass Screening, Median, Middle Aged, Murex, Open bars, Overall donor population, Positive samples, Predonation screening, Pregnant women, Present study, Prevalence, RNA, Viral (blood), Replacement blood donors, Replacement donor population, Replacement donors, Screening, Screening assay, Screening assays, Separate screening assays, Seroepidemiologic Studies, Surface antigen, Transfusion, Transfusion medicine, Urban area, Viral, Viral infections, Viral markers, Viremia (blood), Viremia (diagnosis), Viremia (epidemiology), Viremia (prevention & control), Viremia (transmission), Virus infection, Volunteer blood donors, Volunteer donors, Volunteers, West africa, West african blood donors.
- MESH :
- chemical , blood : Antibodies, Viral, Antigens, Viral, HIV Antibodies, HIV Core Protein p24, HTLV-I Antibodies, HTLV-II Antibodies, Hepatitis B Surface Antigens, Hepatitis C Antibodies, RNA, Viral.
- geographic , epidemiology : Ghana.
- adverse effects : Blood Transfusion.
- blood : Viremia.
- diagnosis : Viremia.
- epidemiology : Viremia.
- prevention & control : Viremia.
- transmission : Viremia.
- Teeft :
- Adolescent, Adult, Allain, Assay, Blackwell science, Blood Donors, Blood donations, Blood donor population, Blood donors, Blood screening, Blood service, Blood services, Blood transfusion, Donation, Donor, East anglia blood centre, Enzyme immunoassay, Enzyme-Linked Immunosorbent Assay, Equatorial guinea, Family, Female, Grey bars, HIV Seroprevalence, Hbsag, Hbsag prevalence, Hepatitis, Hepatocellular carcinoma, High level, Human virus, Humans, Infection, International society, Komfo anokye teaching hospital, Kumasi, Male, Marker, Mass Screening, Median, Middle Aged, Murex, Open bars, Overall donor population, Positive samples, Predonation screening, Pregnant women, Present study, Prevalence, Replacement blood donors, Replacement donor population, Replacement donors, Screening, Screening assay, Screening assays, Separate screening assays, Seroepidemiologic Studies, Surface antigen, Transfusion, Transfusion medicine, Urban area, Viral, Viral infections, Viral markers, Virus infection, Volunteer blood donors, Volunteer donors, Volunteers, West africa, West african blood donors.
Abstract
West Africa is a highly endemic area for viral infections. The prevalence of five viral markers was determined in Ghanaian blood donors.
Url:
DOI: 10.1046/j.1423-0410.2001.00023.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000113
- to stream Istex, to step Curation: 000113
- to stream Istex, to step Checkpoint: 000640
- to stream Main, to step Merge: 001177
- to stream PubMed, to step Corpus: 000718
- to stream PubMed, to step Curation: 000718
- to stream PubMed, to step Checkpoint: 000718
- to stream Ncbi, to step Merge: 000053
- to stream Ncbi, to step Curation: 000053
- to stream Ncbi, to step Checkpoint: 000053
- to stream Main, to step Merge: 001135
- to stream Main, to step Curation: 001105
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Screening for viral markers in volunteer and replacement blood donors in West Africa</title><author><name sortKey="Sarkodie, F" sort="Sarkodie, F" uniqKey="Sarkodie F" first="F." last="Sarkodie">F. Sarkodie</name></author><author><name sortKey="Adarkwa, M" sort="Adarkwa, M" uniqKey="Adarkwa M" first="M." last="Adarkwa">M. Adarkwa</name></author><author><name sortKey="Adu Arkodie, Y" sort="Adu Arkodie, Y" uniqKey="Adu Arkodie Y" first="Y." last="Adu-Sarkodie">Y. Adu-Sarkodie</name></author><author><name sortKey="Candotti, D" sort="Candotti, D" uniqKey="Candotti D" first="D." last="Candotti">D. Candotti</name></author><author><name sortKey="Acheampong, J W" sort="Acheampong, J W" uniqKey="Acheampong J" first="J. W." last="Acheampong">J. W. Acheampong</name></author><author><name sortKey="Allain, J P" sort="Allain, J P" uniqKey="Allain J" first="J. P." last="Allain">J. P. Allain</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:23D73116D46165E68A2BE60E505A8E4D3A8BFB15</idno><date when="2001" year="2001">2001</date><idno type="doi">10.1046/j.1423-0410.2001.00023.x</idno><idno type="url">https://api.istex.fr/document/23D73116D46165E68A2BE60E505A8E4D3A8BFB15/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000113</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000113</idno><idno type="wicri:Area/Istex/Curation">000113</idno><idno type="wicri:Area/Istex/Checkpoint">000640</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000640</idno><idno type="wicri:doubleKey">0042-9007:2001:Sarkodie F:screening:for:viral</idno><idno type="wicri:Area/Main/Merge">001177</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:11840974</idno><idno type="wicri:Area/PubMed/Corpus">000718</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000718</idno><idno type="wicri:Area/PubMed/Curation">000718</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000718</idno><idno type="wicri:Area/PubMed/Checkpoint">000718</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000718</idno><idno type="wicri:Area/Ncbi/Merge">000053</idno><idno type="wicri:Area/Ncbi/Curation">000053</idno><idno type="wicri:Area/Ncbi/Checkpoint">000053</idno><idno type="wicri:doubleKey">0042-9007:2001:Sarkodie F:screening:for:viral</idno><idno type="wicri:Area/Main/Merge">001135</idno><idno type="wicri:Area/Main/Curation">001105</idno><idno type="wicri:Area/Main/Exploration">001105</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Screening for viral markers in volunteer and replacement blood donors in West Africa</title><author><name sortKey="Sarkodie, F" sort="Sarkodie, F" uniqKey="Sarkodie F" first="F." last="Sarkodie">F. Sarkodie</name><affiliation wicri:level="1"><country xml:lang="fr">Ghana</country><wicri:regionArea>Blood Service, Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi</wicri:regionArea><wicri:noRegion>Kumasi</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Microbiology, Komfo Anokye Teaching Hospital, Kumasi</wicri:regionArea><wicri:noRegion>Kumasi</wicri:noRegion></affiliation></author><author><name sortKey="Adarkwa, M" sort="Adarkwa, M" uniqKey="Adarkwa M" first="M." last="Adarkwa">M. Adarkwa</name><affiliation wicri:level="1"><country xml:lang="fr">Ghana</country><wicri:regionArea>Blood Service, Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi</wicri:regionArea><wicri:noRegion>Kumasi</wicri:noRegion></affiliation></author><author><name sortKey="Adu Arkodie, Y" sort="Adu Arkodie, Y" uniqKey="Adu Arkodie Y" first="Y." last="Adu-Sarkodie">Y. Adu-Sarkodie</name><affiliation wicri:level="1"><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Microbiology, Komfo Anokye Teaching Hospital, Kumasi</wicri:regionArea><wicri:noRegion>Kumasi</wicri:noRegion></affiliation></author><author><name sortKey="Candotti, D" sort="Candotti, D" uniqKey="Candotti D" first="D." last="Candotti">D. Candotti</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>National Blood Service, East Anglia Blood Centre, Cambridge</wicri:regionArea><wicri:noRegion>Cambridge</wicri:noRegion></affiliation></author><author><name sortKey="Acheampong, J W" sort="Acheampong, J W" uniqKey="Acheampong J" first="J. W." last="Acheampong">J. W. Acheampong</name><affiliation wicri:level="1"><country xml:lang="fr">Ghana</country><wicri:regionArea>Blood Service, Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi</wicri:regionArea><wicri:noRegion>Kumasi</wicri:noRegion></affiliation></author><author><name sortKey="Allain, J P" sort="Allain, J P" uniqKey="Allain J" first="J. P." last="Allain">J. P. Allain</name><affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Division of Transfusion Medicine, Department of Haematology, University of Cambridge, Cambridge</wicri:regionArea><orgName type="university">Université de Cambridge</orgName><placeName><settlement type="city">Cambridge</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Angleterre de l'Est</region></placeName></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Royaume-Uni</country></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Vox Sanguinis</title><title level="j" type="alt">VOX SANGUINIS</title><idno type="ISSN">0042-9007</idno><idno type="eISSN">1423-0410</idno><imprint><biblScope unit="vol">80</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="142">142</biblScope><biblScope unit="page" to="147">147</biblScope><biblScope unit="page-count">6</biblScope><publisher>Blackwell Science Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2001-04">2001-04</date></imprint><idno type="ISSN">0042-9007</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0042-9007</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Allain</term><term>Antibodies, Viral (blood)</term><term>Antigens, Viral (blood)</term><term>Assay</term><term>Blackwell science</term><term>Blood Donors</term><term>Blood Transfusion (adverse effects)</term><term>Blood donations</term><term>Blood donor population</term><term>Blood donors</term><term>Blood screening</term><term>Blood service</term><term>Blood services</term><term>Blood transfusion</term><term>Donation</term><term>Donor</term><term>East anglia blood centre</term><term>Enzyme immunoassay</term><term>Enzyme-Linked Immunosorbent Assay</term><term>Equatorial guinea</term><term>Family</term><term>Female</term><term>Ghana (epidemiology)</term><term>Grey bars</term><term>HIV Antibodies (blood)</term><term>HIV Core Protein p24 (blood)</term><term>HIV Seroprevalence</term><term>HTLV-I Antibodies (blood)</term><term>HTLV-II Antibodies (blood)</term><term>Hbsag</term><term>Hbsag prevalence</term><term>Hepatitis</term><term>Hepatitis B Surface Antigens (blood)</term><term>Hepatitis C Antibodies (blood)</term><term>Hepatocellular carcinoma</term><term>High level</term><term>Human virus</term><term>Humans</term><term>Infection</term><term>International society</term><term>Komfo anokye teaching hospital</term><term>Kumasi</term><term>Male</term><term>Marker</term><term>Mass Screening</term><term>Median</term><term>Middle Aged</term><term>Murex</term><term>Open bars</term><term>Overall donor population</term><term>Positive samples</term><term>Predonation screening</term><term>Pregnant women</term><term>Present study</term><term>Prevalence</term><term>RNA, Viral (blood)</term><term>Replacement blood donors</term><term>Replacement donor population</term><term>Replacement donors</term><term>Screening</term><term>Screening assay</term><term>Screening assays</term><term>Separate screening assays</term><term>Seroepidemiologic Studies</term><term>Surface antigen</term><term>Transfusion</term><term>Transfusion medicine</term><term>Urban area</term><term>Viral</term><term>Viral infections</term><term>Viral markers</term><term>Viremia (blood)</term><term>Viremia (diagnosis)</term><term>Viremia (epidemiology)</term><term>Viremia (prevention & control)</term><term>Viremia (transmission)</term><term>Virus infection</term><term>Volunteer blood donors</term><term>Volunteer donors</term><term>Volunteers</term><term>West africa</term><term>West african blood donors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>ARN viral (sang)</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anticorps anti-HTLVI (sang)</term><term>Anticorps anti-HTLVII (sang)</term><term>Anticorps anti-VIH (sang)</term><term>Anticorps antiviraux (sang)</term><term>Anticorps de l'hépatite C (sang)</term><term>Antigènes de surface du virus de l'hépatite B (sang)</term><term>Antigènes viraux (sang)</term><term>Bénévoles</term><term>Donneurs de sang</term><term>Dépistage systématique</term><term>Famille</term><term>Femelle</term><term>Ghana (épidémiologie)</term><term>Humains</term><term>Mâle</term><term>Protéine de capside p24 du VIH (sang)</term><term>Séroprévalence du VIH</term><term>Test ELISA</term><term>Transfusion sanguine (effets indésirables)</term><term>Virémie ()</term><term>Virémie (diagnostic)</term><term>Virémie (sang)</term><term>Virémie (transmission)</term><term>Virémie (épidémiologie)</term><term>Études séroépidémiologiques</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term><term>Antigens, Viral</term><term>HIV Antibodies</term><term>HIV Core Protein p24</term><term>HTLV-I Antibodies</term><term>HTLV-II Antibodies</term><term>Hepatitis B Surface Antigens</term><term>Hepatitis C Antibodies</term><term>RNA, Viral</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ghana</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Blood Transfusion</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Viremia</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Viremia</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Virémie</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Transfusion sanguine</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Viremia</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Viremia</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>ARN viral</term><term>Anticorps anti-HTLVI</term><term>Anticorps anti-HTLVII</term><term>Anticorps anti-VIH</term><term>Anticorps antiviraux</term><term>Anticorps de l'hépatite C</term><term>Antigènes de surface du virus de l'hépatite B</term><term>Antigènes viraux</term><term>Protéine de capside p24 du VIH</term><term>Virémie</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Viremia</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ghana</term><term>Virémie</term></keywords><keywords scheme="Teeft" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Allain</term><term>Assay</term><term>Blackwell science</term><term>Blood Donors</term><term>Blood donations</term><term>Blood donor population</term><term>Blood donors</term><term>Blood screening</term><term>Blood service</term><term>Blood services</term><term>Blood transfusion</term><term>Donation</term><term>Donor</term><term>East anglia blood centre</term><term>Enzyme immunoassay</term><term>Enzyme-Linked Immunosorbent Assay</term><term>Equatorial guinea</term><term>Family</term><term>Female</term><term>Grey bars</term><term>HIV Seroprevalence</term><term>Hbsag</term><term>Hbsag prevalence</term><term>Hepatitis</term><term>Hepatocellular carcinoma</term><term>High level</term><term>Human virus</term><term>Humans</term><term>Infection</term><term>International society</term><term>Komfo anokye teaching hospital</term><term>Kumasi</term><term>Male</term><term>Marker</term><term>Mass Screening</term><term>Median</term><term>Middle Aged</term><term>Murex</term><term>Open bars</term><term>Overall donor population</term><term>Positive samples</term><term>Predonation screening</term><term>Pregnant women</term><term>Present study</term><term>Prevalence</term><term>Replacement blood donors</term><term>Replacement donor population</term><term>Replacement donors</term><term>Screening</term><term>Screening assay</term><term>Screening assays</term><term>Separate screening assays</term><term>Seroepidemiologic Studies</term><term>Surface antigen</term><term>Transfusion</term><term>Transfusion medicine</term><term>Urban area</term><term>Viral</term><term>Viral infections</term><term>Viral markers</term><term>Virus infection</term><term>Volunteer blood donors</term><term>Volunteer donors</term><term>Volunteers</term><term>West africa</term><term>West african blood donors</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Bénévoles</term><term>Donneurs de sang</term><term>Dépistage systématique</term><term>Famille</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Séroprévalence du VIH</term><term>Test ELISA</term><term>Transfusion sanguine</term><term>Don</term><term>Virémie</term><term>Zone urbaine</term><term>Études séroépidémiologiques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract">West Africa is a highly endemic area for viral infections. The prevalence of five viral markers was determined in Ghanaian blood donors.</div></front></TEI><affiliations><list><country><li>Ghana</li><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Angleterre de l'Est</li></region><settlement><li>Cambridge</li></settlement><orgName><li>Université de Cambridge</li></orgName></list><tree><country name="Ghana"><noRegion><name sortKey="Sarkodie, F" sort="Sarkodie, F" uniqKey="Sarkodie F" first="F." last="Sarkodie">F. Sarkodie</name></noRegion><name sortKey="Acheampong, J W" sort="Acheampong, J W" uniqKey="Acheampong J" first="J. W." last="Acheampong">J. W. Acheampong</name><name sortKey="Adarkwa, M" sort="Adarkwa, M" uniqKey="Adarkwa M" first="M." last="Adarkwa">M. Adarkwa</name><name sortKey="Adu Arkodie, Y" sort="Adu Arkodie, Y" uniqKey="Adu Arkodie Y" first="Y." last="Adu-Sarkodie">Y. Adu-Sarkodie</name><name sortKey="Sarkodie, F" sort="Sarkodie, F" uniqKey="Sarkodie F" first="F." last="Sarkodie">F. Sarkodie</name></country><country name="Royaume-Uni"><noRegion><name sortKey="Candotti, D" sort="Candotti, D" uniqKey="Candotti D" first="D." last="Candotti">D. Candotti</name></noRegion><name sortKey="Allain, J P" sort="Allain, J P" uniqKey="Allain J" first="J. P." last="Allain">J. P. Allain</name><name sortKey="Allain, J P" sort="Allain, J P" uniqKey="Allain J" first="J. P." last="Allain">J. P. Allain</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001105 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001105 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:23D73116D46165E68A2BE60E505A8E4D3A8BFB15
|texte= Screening for viral markers in volunteer and replacement blood donors in West Africa
}}
| This area was generated with Dilib version V0.6.31. |  |